查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458737

Sanger定序2024 年全球市场报告

Sanger Sequencing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

Sanger定序市场规模预计在未来几年将快速成长。到 2028 年，将以 17.8% 的年复合成长率（CAGR）增长至 53 亿美元。预测期内的预期增长是由临床基因组学整合程度的提高、农业基因组学应用的扩大、对药物安全性和药物基因组学的日益关注、产前和新生儿筛检的使用增加以及环境DNA 分析的采用增加等因素推动的。这段时期的主要趋势包括技术进步、对次世代定序技术的需求增加、临床诊断应用的扩大、基因组学研究投资的增加以及基因组学在个人化医疗中的扩大使用。

预计遗传疾病数量的增加可能是近期Sanger定序市场扩张的驱动力。遗传疾病（遗传性疾病）是由个体DNA（携带遗传讯息的遗传物质）异常或突变引起的。Sanger定序透过准确确定特定基因或 DNA 区域内的核苷酸（DNA 的组成部分）序列，在诊断遗传性疾病中发挥重要作用。例如，美国政府美国遗传和罕见疾病资讯中心 (GARD) 的资料显示，到 2024 年 2 月，大约有 7,000 种已知的罕见遗传疾病；大约十分之一，约 3000 万人受到影响。因此，遗传疾病的扩散成为推动Sanger定序市场成长的催化剂。

Sanger定序市场的主要参与者正在投资先进系统的开发，以推动收益成长。这些先进的系统专为提高吞吐量而设计，允许同时处理多个样品。例如，美国酵素及相关产品专业製造商 Promega 公司于 2021 年 10 月推出了 ProDye Terminator 定序系统。该系统与所有毛细管电泳 (CE) 平台相容，包括紧凑型桌上型 Spectrum Compact CE 系统。该系统允许实验室在各种规模的实验室的任何 CE 仪器上进行Sanger定序。 ProDye Terminator 定序系统利用专有的热稳定性 DNA聚合酵素，可部署在各种仪器上，包括 Spectrum Compact CE 系统、SeqStudio 遗传分析仪和 Applied Biosystems 遗传分析仪。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球Sanger定序市场，依定序细分、实际与预测，2018-2023、2023-2028、2033
  • 霰弹枪定序
  • 标靶基因序列测定序
  • 其他序列
  • 全球Sanger定序市场，依实验室细分，实际与预测，2018-2023、2023-2028、2033
  • 湿实验室
  • 干燥实验室
  • 全球Sanger定序市场，依研究、实际及预测细分，2018-2023、2023-2028、2033
  • 公司内部
  • 外包
  • 全球Sanger定序市场，依应用细分、实际与预测，2018-2023、2023-2028、2033
  • 诊断
  • 生物标记和癌症
  • 生殖健康
  • 个人化医疗
  • 法医学
  • 其他应用
  • 全球Sanger定序市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 学术的
  • 政府研究所
  • 製药公司
  • 生技公司
  • 医院
  • 诊所

第 7 章 区域/国家分析

  • 全球Sanger定序市场、地区、实际与预测，2018-2023、2023-2028、2033
  • 全球Sanger定序市场，依国家、实际与预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • Sanger定序市场竞争格局
  • Sanger定序市场公司概况
    • Hoffmann-La Roche
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Eurofins Scientific
    • Illumina Inc.

第31章 其他大型创新企业

  • Beckman Coulter
  • PerkinElmer Inc.
  • BGI Group
  • LGC Limited
  • GenScript
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • GENEWIZ Inc.
  • Quintara Biosciences
  • CeMIA SA
  • Source BioScience
  • Microsynth AG
  • Fasteris SA
  • GenHunter Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r16719

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.75 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth observed during the historical period can be attributed to several factors, including heightened demand for research, expanding applications in medical diagnostics, growing pharmaceutical development activities, increased utilization in agriculture, rising demand for forensic analysis, enhanced discovery of biomarkers, and growing studies in genetic evolution.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.30 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth anticipated in the forecast period is driven by several factors, including the increasing integration of clinical genomics, expanded applications in agricultural genomics, heightened focus on drug safety and pharmacogenomics, rising utilization of prenatal and newborn screening, and increased adoption of environmental DNA analysis. Major trends expected during this period include technological advancements, a growing demand for next-generation sequencing technologies, expanding applications in clinical diagnostics, increased investments in genomics research, and the widening use of genomics in personalized medicine.

The projected increase in genetic illnesses is set to drive the expansion of the Sanger sequencing market in the foreseeable future. Genetic illnesses, or genetic disorders, stem from abnormalities or mutations in an individual's DNA, the genetic material responsible for carrying hereditary information. Sanger sequencing plays a crucial role in diagnosing genetic illnesses by precisely determining the sequence of nucleotides (the DNA building blocks) within a specific gene or DNA region. For instance, data from the Genetic Rare Diseases Information Center (GARD), a US-based government agency, revealed approximately 7,000 known rare genetic diseases by February 2024, affecting approximately 1 in 10 individuals or around 30 million people in the United States during 2020-2021. Consequently, the surge in genetic illnesses acts as a catalyst propelling the growth of the Sanger sequencing market.

Major players within the Sanger sequencing market are investing in the development of advanced systems to drive revenue growth. These advanced systems are engineered to accommodate higher throughput, enabling the simultaneous processing of multiple samples. For example, in October 2021, Promega Corporation, a US-based manufacturer specializing in enzymes and related products, introduced the ProDye Terminator Sequencing System. This system is compatible with all capillary electrophoresis (CE) platforms, including the compact benchtop Spectrum Compact CE System. It enables research laboratories to conduct Sanger sequencing on any CE instrument, catering to a range of laboratory sizes. Leveraging a proprietary thermostable DNA polymerase, the ProDye Terminator Sequencing System can be deployed on various instruments such as the Spectrum Compact CE System, SeqStudio Genetic Analyzers, and Applied Biosystems Genetic Analyzers.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2023. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Sanger Sequencing Market Size and Growth

  • 5.1. Global Sanger Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Sanger Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Sanger Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Illumina Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking

33. Global Sanger Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sanger Sequencing Market

35. Sanger Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Sanger Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer